Biological markers in dementia

References

• Svennerholm L, Gottfries C G, Karlsson I. Neurochemical changes in white matter of patients with Alzheimer's disease. Gothenburg University, Department of Psychiatry and Neurochemistry. 1987, Accepted for publication in a book from the NATO conference, “Multidisciplinary Approach to Myelin Diseases”
   Google Scholar
• Reisberg B. Alzheimer's disease. The Standard Reference. The Free Press, New York 1983
   Google Scholar
• Gottfries C G, Adolfsson R, Aquilonius S M, Carlsson A, Eckernas S M, Nordberg A, Oreland L, Svennerholm L, Wiberg A, Winblad B. Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiological Ageing 1983; 4: 261–71
   PubMed Web of Science ®Google Scholar
• Gottfries C G, Bartfai T, Carlsson A, Eckernäs SÅ, Svennerholm L. Multiple biochemical deficits in both gray and white matter of Alzheimer brains. Prog Neuropsychopharmacol Biol Psychiatry 1986; 10: 405–13
   PubMed Web of Science ®Google Scholar
• Adolfsen R, Gottfries C G, Roos B E, Winblad B. Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 1979; 135: 216–23
   PubMed Web of Science ®Google Scholar
• Hardy J, Adolfsson R, Alafuzott I, Bucht G, Marcusson J, Nyberg P, Perdahl E, Wester P, Winblad B. Review: transmitter deficits in Alzheimer's disease. Neurochem Int 1985; 4: 545–63
   Google Scholar
• Gottfries C G, Gottfries I, Roos B E. Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and Parkinsonism. J Neurochem 1969; 16: 1341–5
   PubMed Web of Science ®Google Scholar
• Soininen H, MacDonald E, Rekonen M, Riekki-Nen P J. Homovanillic acid and 5-hydroxyindole-acetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Acta Neurol Scand 1981; 64: 101–7
   PubMed Web of Science ®Google Scholar
• Seeldrayers P, Messina D, Desmedt D, Dalesio O, Hildebrand J. CSF levels of neurotransmitters in Alzheimer-type dementia. Effects of ergoloid mesylate. Acta Neurol Scand 1985; 71: 411–14
   PubMed Web of Science ®Google Scholar
• Parnetti L, Gottfries J, Karlsson I, Långström G, Gottfries C G, Svennerholm L. Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectometry. Acta Psychiatr Scand 1987; 75: 542–8
   PubMed Web of Science ®Google Scholar
• Bråne G, Gottfries C G, Karlsson I, Lekman A, Parnetti L, Svennerholm L. Monoamine metabolites in CBF correlated to psychological variables in patients with dementia of Alzheimer type. Gothenburg University, Department of Psychiatry and Neurochemistry. 1987, Accepted for publication in Alzheimer Disease and Associated Disorders – an International Journal
   Google Scholar
• Volicer L, Direnfeld L K, Freedman M, Albert M L, Langlais P J, Bird E D. Serotonin and 5-hydroxyindoleacetic acid in CSF. Difference in Parkinson's disease and dementia of the Alzheimer type. Arch Neurol 1985; 42: 127–9
   PubMedGoogle Scholar
• Carroll B J, Feinberg M, Greden J F, Tarika J, Albala A, Haskett R F, James N M, Kronfol Z, Lohr N, Steiner M, de Vigne J P, Young E. A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Arch Gen Psychiatry 1981; 38: 15–22
   PubMed Web of Science ®Google Scholar
• Balldin J, Gottfries C G, Karlsson I, Lindstedt G, Långström G, Wålinder J. Dexamethasone suppression test and serum prolactin in dementia disorders. Br J Psychiatry 1983; 143: 277–81
   PubMed Web of Science ®Google Scholar
• McAllister T W, Hays L R. TRH test, DST, and response to desipramine in primary degenerative dementia. Biol Psychiatry 1987; 22: 189–93
   PubMed Web of Science ®Google Scholar
• Balldin J, Gottfries C G, Karlsson I, Lindstedt G, Långström G, Svennerholm L. Relationship between DST and the serotonergic system. Results from treatments with two 5-HT reuptake blockers in dementia disorders. Int J Geriatr Psychiatr 1988; 3: 17–26
   Web of Science ®Google Scholar
• Balldin J, Bolle P, Edén S, Eriksson E, Modigh K. Effects of electroconvulsive treatment on growth hormone secretion induced monoamine receptor agonists in reserpine-pretreated rats. Psychoneuroendocrinology 1980; 5: 329–37
   PubMed Web of Science ®Google Scholar
• Lal S, Tolis G, Martin J B, Brown G M, Guyda H. Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone and thyroid stimulating hormone in the serum of normal men. J Clin Endocrinol Metabol 1975; 41: 827–32
   PubMed Web of Science ®Google Scholar
• Matussek N, Ackenheil M, Hippius H, Müller F, Schröder H T, Schultes H, Wasilewski B. Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatric Res 1980; 2: 25–36
   PubMed Web of Science ®Google Scholar
• Balldin J, Gottfries C G, Lindstedt G, Långström G, Svennerholm L. The clonidine growth hormone test in patients with dementia disorders. Relation to clinical status and cerebrospinal fluid metabolite levels. Gothenburg University, Department of Psychiatry and Neurochemistry. 1987, Submitted for publication
   Google Scholar
• Balldin J, Gottfries C G, Lindstedt G, Långström G, Svennerholm L. TRH stimulation test and dementia disorders. Relationship to CSF metabolites and the clinical status. Gothenburg University, Department of Psychiatry and Neurochemistry. 1987, Submitted for publication
   Google Scholar
• el Sobky A. Anterior pituitary response to thyrotrophin-releasing hormone in senile dementia (Alzheimer type and elderly normals). Acta Psychiatr Scand 1986; 74: 13–17
   PubMed Web of Science ®Google Scholar
• Holmes J M. Cerebral manifestations of vitamin-B12 deficiency. Br Med J 1956; 2: 1394–8
   PubMedGoogle Scholar
• Droller H, Dossett J A. Vitamin B12 levels in senile dementia and confusional states. Geriatrics 1959; 14: 367–73
   PubMedGoogle Scholar
• Cole M G, Prchal J F. Low serum vitamin B12 in Alzheimer-type dementia. Age and ageing 1984; 13: 101–5
   PubMed Web of Science ®Google Scholar
• Strachan R W, Hendersen J G. Psychiatry syndromes due to avitaminosis B12 with normal blood and marrow. J Med 1965; 34: 303–17
   Google Scholar
• Gross J S, Weintraub N T, Neurfeld R R, Libow L S. Pernicious anemia in the demented patient without anemia or macrocytosis. A case for early recognition. J Am Geriatr Soc 1986; 34: 612–14
   PubMed Web of Science ®Google Scholar
• Zucker D K, Livingston R L, Nakra R, Clayton P J. B12 deficiency and psychiatric disorders: Case report and literature review. Biol Psychiatry 1981; 16: 197–205
   PubMed Web of Science ®Google Scholar
• Adolfsson R, Gottfries C G, Oreland L, Wiberg Å, Winblad B. Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 1980; 27: 1029–34
   PubMed Web of Science ®Google Scholar
• Freidhoff A J, Miller J C. Platelet MAO as function of nongenetic factors. Schizophrenia Bull 1980; 6: 314–19
   PubMed Web of Science ®Google Scholar